We report 2 cases of plexiform angiomyxoid myofibroblastic tumor of the stomach, a tumor entity that has not been described previously. The patients were a 50-year-old man (case 1) and a 68-year-old man (case 2). In case 1, the patient presented with acute abdominal pain. The tumor in case 2 was incidentally found at laparoscopic cholecystectomy. Grossly, the tumors were 4.0 cm (case 1) and 4.5 cm (case 2) in their greatest dimension, and they were recognized as submucosal tumors. The tumor caused gastric perforation in case 1. Histologically, the tumors extended from the serosa to the submucosa of the gastric wall, showing a plexiform growth pattern. Bland spindle tumor cells were observed, and they were separated by abundant intercellular myxoid matrix. The stroma was rich in small vessels. Immunohistochemically, the tumor cells were positive for alpha-smooth muscle actin and muscle actin, and negative for KIT, CD34, and S-100 protein. Electron microscopic findings were consistent with the myofibroblastic nature of the tumor cells. No mutations were found in the c-kit and platelet-derived growth factor receptor alpha genes. Although clinical follow-up data were insufficient, the histologic appearances suggested the benign nature of the tumors. However, the tumor in case 1 caused gastric perforation and necessitated an emergency operation.
Although radiological diagnostics have been progressing, pathological diagnosis remains the most reliable method for diagnosing liver tumors. In some cases, definite pathological diagnosis cannot be obtained by histological evaluation alone, especially when the sample is a small biopsy; in such cases, immunohistochemical staining is very useful. Immunohistochemistry is the most frequently used technique for molecular pathological diagnosis due to its broad application, ease of performance and evaluation, and reasonable cost. The results occasionally reflect specific genetic mutations. The immunohistochemical markers of hepatocellular carcinoma include those of hepatocellular differentiation—such as hepatocyte paraffin 1 and arginase-1—and those of malignant hepatocytes—such as glypican-3, heat shock protein 70, and glutamine synthetase (GS). To classify the subtypes of hepatocellular adenoma, examination of several immunohistochemical markers, such as liver fatty acid-binding protein, GS, and serum amyloid A, is indispensable. Immunohistochemical staining for GS is also important for the diagnosis of focal nodular hyperplasia. The representative immunohistochemical markers of intrahepatic cholangiocarcinoma include cytokeratin (CK) 7 and CK19. In this article, we provide an overview of the application of immunohistochemistry in the pathological diagnosis of liver tumors referring to the association with genetic alterations. Furthermore, we aimed to explain the practical points in the differential diagnosis of liver tumors by immunohistochemical staining.
Although there has been an increasing number of case reports on inflammatory bowel disease complicated by cytomegalovirus infection, few reports have described its prevalence. The aim of this study was to investigate the prevalence of cytomegalovirus infection in inflammatory bowel disease and clarify the clinicopathologic features of the cases. We studied 55 biopsy specimens and 39 surgical specimens taken from patients clinically diagnosed as having ulcerative colitis, and 49 biopsy specimens and 30 surgical specimens from patients clinically diagnosed as having Crohn's disease. In all cases cytomegalovirus infection was histopathologically examined by means of hematoxylin and eosin and immunohistochemical staining to detect inclusion bodies in specimens. Cytomegalovirus infection was confirmed in 1 of 55 biopsy specimens and in 8 of 39 surgical specimens obtained from the cases with ulcerative colitis. No cytomegalovirus inclusion bodies were exhibited in the 49 biopsy specimens and 30 surgical specimens taken from patients with Crohn's disease. Cytomegalovirus infection was detected rather frequently (21 percent) in the surgical specimens of ulcerative colitis, and all cases were steroid resistant. The possibility of cytomegalovirus infection should always be taken into account in patients with ulcerative colitis who are resistant to steroid therapy.